Skip to content

An fMRI Study of Opioid-related Changes in Neural Activity

An fMRI Study of Opioid-related Changes in Neural Activity

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02818036
Enrollment
82
Registered
2016-06-29
Start date
2016-08-31
Completion date
2018-06-21
Last updated
2019-07-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Social Acceptance

Brief summary

The purpose of the study is to explore the effect of blocking opioids on affiliation-related neural activity.

Interventions

DRUGNaltrexone
DRUGPlacebo

Sponsors

Tristen Inagaki
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* good health * between the ages of 18 and 35, * fluent in English * right-handed (for the fMRI scan)

Exclusion criteria

* Self-reported current or past diagnoses of physical or mental illness. * Score on the Patient Health Questionnaire (depressive symptoms) above a 13 * Positive urine drug test (for Tetrahydrocannabinol (THC), Opiates, Cocaine, Amphetamine (AMP), and Methamphetamine (mAMP)) * Positive urine pregnancy test * Use of any prescription medication, except for birth control * Use of any over-the-counter medications on the day of the fMRI session and 24 hours after the fMRI session * Self-reported problems with liver functioning, including hepatitis or liver failure * Difficulty swallowing or taking pills * BMI greater than 35 or weight greater than 400 lbs * Claustrophobia * Nonremovable metal in the body

Design outcomes

Primary

MeasureTime frameDescription
Bold Oxygen-level Dependent (BOLD) Activations in Prespecified ROIsapproximately one hour after taking study drugIn the MRI scanner, participants read sentences written by people they knew and people they did not know in a block design. Brain activity was measured as BOLD activity in response to reading sentences from known (vs. unknown) people using functional magnetic resonance imaging (FMRI). Based on a priori hypotheses, brain activity was masked to activity in structural regions-of-interest (ROIs) of the ventral striatum (VS) and middle-insula (MI).
Self-reported Feelings of Connection in Response to the Scanner Tasksapproximately two hours after taking study drugfeelings of social connection in response to reading sentences from known people (i.e. average of how connected, touched, warm did you feel). Feelings were reported on a scale of 1 (not at all) to 7 (very) such that higher numbers reflect greater feelings of social connection. time frame was mistakenly entered as the start of the fMRI scan, but participants reported on their feelings of social connection after the scan. Thus, the outcome measure time frame is reported as two, rather than one, hour after taking the study drug.

Countries

United States

Participant flow

Participants by arm

ArmCount
Naltrexone
single 50mg dose of naltrexone Naltrexone
40
Sugar Pill
single sugar pill Placebo
40
Total80

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall Studyhead did not fit in fMRI scanner headres10
Overall StudyWithdrawal by Subject10

Baseline characteristics

CharacteristicNaltrexoneSugar PillTotal
Age, Continuous21.90 years
STANDARD_DEVIATION 3.49
22.88 years
STANDARD_DEVIATION 3.2
22.39 years
STANDARD_DEVIATION 3.362
Body Mass Index (BMI)24.30 kg/m^2
STANDARD_DEVIATION 3.6
23.42 kg/m^2
STANDARD_DEVIATION 2.61
23.86 kg/m^2
STANDARD_DEVIATION 3.15
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
10 Participants12 Participants22 Participants
Race (NIH/OMB)
Black or African American
1 Participants2 Participants3 Participants
Race (NIH/OMB)
More than one race
2 Participants2 Participants4 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants1 Participants1 Participants
Race (NIH/OMB)
White
27 Participants23 Participants50 Participants
Sex: Female, Male
Female
27 Participants21 Participants48 Participants
Sex: Female, Male
Male
13 Participants19 Participants32 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 400 / 40
other
Total, other adverse events
30 / 4020 / 40
serious
Total, serious adverse events
0 / 400 / 40

Outcome results

Primary

Bold Oxygen-level Dependent (BOLD) Activations in Prespecified ROIs

In the MRI scanner, participants read sentences written by people they knew and people they did not know in a block design. Brain activity was measured as BOLD activity in response to reading sentences from known (vs. unknown) people using functional magnetic resonance imaging (FMRI). Based on a priori hypotheses, brain activity was masked to activity in structural regions-of-interest (ROIs) of the ventral striatum (VS) and middle-insula (MI).

Time frame: approximately one hour after taking study drug

Population: all participants, 3 excluded from sugar pill group (1 for poor registration during preprocessing, 1 for technical error with task presentation, 1 for signal dropout in primary regions of interest)

ArmMeasureValue (MEAN)Dispersion
NaltrexoneBold Oxygen-level Dependent (BOLD) Activations in Prespecified ROIs0.117 BOLD signalStandard Error 0.033
Sugar PillBold Oxygen-level Dependent (BOLD) Activations in Prespecified ROIs0.2545 BOLD signalStandard Error 0.061
p-value: <0.01t-test, 1 sided
Primary

Self-reported Feelings of Connection in Response to the Scanner Tasks

feelings of social connection in response to reading sentences from known people (i.e. average of how connected, touched, warm did you feel). Feelings were reported on a scale of 1 (not at all) to 7 (very) such that higher numbers reflect greater feelings of social connection. time frame was mistakenly entered as the start of the fMRI scan, but participants reported on their feelings of social connection after the scan. Thus, the outcome measure time frame is reported as two, rather than one, hour after taking the study drug.

Time frame: approximately two hours after taking study drug

Population: All participants. Ratings from 1 participant in the naltrexone group were misplaced. 1 participant from the sugar pill group did not follow instructions and so ratings were not included in final analyses.

ArmMeasureValue (MEAN)Dispersion
NaltrexoneSelf-reported Feelings of Connection in Response to the Scanner Tasks4.576 scores on a scaleStandard Deviation 0.848
Sugar PillSelf-reported Feelings of Connection in Response to the Scanner Tasks4.766 scores on a scaleStandard Deviation 0.895
p-value: 0.338t-test, 2 sided

Source: ClinicalTrials.gov · Data processed: Feb 14, 2026